VPAResearch: Market Research Reports

Influenza A H7N9 Infection Pipeline Overview The Q4 Influenza A H7N9 Infection pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline...

Influenza A Virus H3N2 Subtype Infections Pipeline Overview The Q4 Influenza A Virus H3N2 Subtype Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly...

Influenza B Infections Pipeline Overview The Q4 Influenza B Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs...

Insulin Resistance Pipeline Overview The Q4 Insulin Resistance pipeline report is part of the VPA Metabolic Disorder disease pipeline service. This quarterly review describes the pipeline of drugs und...

Japanese Encephalitis Pipeline Overview The Q4 Japanese Encephalitis pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs u...

Kaposi Sarcoma Pipeline Overview The Q4 Kaposi Sarcoma pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under developme...

Kidney Transplant Rejection Pipeline Overview The Q4 Kidney Transplant Rejection pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of...

Klebsiella pneumoniae Infections Pipeline Overview The Q4 Klebsiella pneumoniae Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes t...

Lassa Fever Pipeline Overview The Q4 Lassa Fever pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for...

Leishmaniasis (Kala-Azar) Pipeline Overview The Q4 Leishmaniasis (Kala-Azar) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of...

Liver Transplant Rejection Pipeline Overview The Q4 Liver Transplant Rejection pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of d...

Lung Transplant Rejection Pipeline Overview The Q4 Lung Transplant Rejection pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of dru...

Lyme Disease Pipeline Overview The Q4 Lyme Disease pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development f...

Marburgvirus Infections Pipeline Overview The Q4 Marburgvirus Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of dru...

Measles Pipeline Overview The Q4 Measles pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Measles...

Meningitis Pipeline Overview The Q4 Meningitis pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for M...

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections Pipeline Overview The Q4 Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections pipeline report is part of the VPA 110 Infectio...

Microscopic Polyangiitis (MPA) Pipeline Overview The Q4 Microscopic Polyangiitis (MPA) pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipel...

Middle East Respiratory Syndrome (MERS) Pipeline Overview The Q4 Middle East Respiratory Syndrome (MERS) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly revi...

Mumps Pipeline Overview The Q4 Mumps pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Mumps, prov...

Myasthenia Gravis Pipeline Overview The Q4 Myasthenia Gravis pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of drugs under develop...

Neisseria meningitidis Infections Pipeline Overview The Q4 Neisseria meningitidis Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes...

Onychomycosis (Tinea Unguium) Pipeline Overview The Q4 Onychomycosis (Tinea Unguium) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pip...

Osteomyelitis Pipeline Overview The Q4 Osteomyelitis pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development...

Peanut Allergy Pipeline Overview The Q4 Peanut Allergy pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of drugs under development f...

Pemphigus Vulgaris Pipeline Overview The Q4 Pemphigus Vulgaris pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of drugs under devel...

Pertussis (Whooping Cough) Pipeline Overview The Q4 Pertussis (Whooping Cough) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline...

Phenylketonuria (PKU) Pipeline Overview The Q4 Phenylketonuria (PKU) pipeline report is part of the VPA Metabolic Disorder disease pipeline service. This quarterly review describes the pipeline of dru...

Pituitary ACTH Hypersecretion Pipeline Overview The Q4 Pituitary ACTH Hypersecretion pipeline report is part of the VPA Metabolic Disorder disease pipeline service. This quarterly review describes the...

Plague Pipeline Overview The Q4 Plague pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Plague, p...

Polio (Poliomyelitis) Pipeline Overview The Q4 Polio (Poliomyelitis) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs u...

Pompe Disease Pipeline Overview The Q4 Pompe Disease pipeline report is part of the VPA Metabolic Disorder disease pipeline service. This quarterly review describes the pipeline of drugs under develop...

Post Menopausal Osteoporosis Pipeline Overview The Q4 Post Menopausal Osteoporosis pipeline report is part of the VPA Metabolic Disorder disease pipeline service. This quarterly review describes the p...

Progressive Multifocal Leukoencephalopathy Pipeline Overview The Q4 Progressive Multifocal Leukoencephalopathy pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterl...

Pyelonephritis Pipeline Overview The Q4 Pyelonephritis pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under developme...

Rabies Pipeline Overview The Q4 Rabies pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Rabies, p...

Ragweed Pollen Allergy Pipeline Overview The Q4 Ragweed Pollen Allergy pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of drugs und...

Resistant Pseudomonas aeruginosa Infections Pipeline Overview The Q4 Resistant Pseudomonas aeruginosa Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarte...

Rhinovirus Infections Pipeline Overview The Q4 Rhinovirus Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs u...

Rotavirus Infections Pipeline Overview The Q4 Rotavirus Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs und...

Rubella (German Measles) Pipeline Overview The Q4 Rubella (German Measles) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of d...

Schistosomiasis Pipeline Overview The Q4 Schistosomiasis pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under develop...

Severe Acute Respiratory Syndrome (SARS) Pipeline Overview The Q4 Severe Acute Respiratory Syndrome (SARS) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly re...

Sjogren Syndrome Pipeline Overview The Q4 Sjogren Syndrome pipeline report is part of the VPA immunology disease pipeline service. This quarterly review describes the pipeline of drugs under developme...

Smallpox Pipeline Overview The Q4 Smallpox pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Small...

Streptococcus pyogenes Infections Pipeline Overview The Q4 Streptococcus pyogenes Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes...

Tetanus Pipeline Overview The Q4 Tetanus pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Tetanus...

Tinea pedis (Athlete Foot) Pipeline Overview The Q4 Tinea pedis (Athlete Foot) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline...

Toxoplasmosis Pipeline Overview The Q4 Toxoplasmosis pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development...

Tularaemia Pipeline Overview The Q4 Tularaemia pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for T...